Patents are the golden eggs of the booming psychedelic space. In an industry that revolves around substances that are found in nature (such as psilocybin, ibogaine or DMT) or compounds whose patents have already expired (LSD and MDMA), new patents are the primary way in which companies can guarantee their place in the market and provide a sense of security to investors. Receiving a patent can be a sign that the company has a strong development pipeline or, at the very least, clear plans for the future.
However, it’s not always easy to understand the process by which a company is granted a patent or the implications that said patents might have in the long run, and less so in a new market such as this one.
